Weill Cornell Medicine is dramatically expanding its campus and research footprint in New York City by securing five floors of 1334 York Ave., the current home of Sotheby's auction house, the institution announced today.
Located one block from Weill Cornell Medicine’s main campus on Manhattan’s Upper East Side, the site will add approximately 200,000 square feet of dedicated research space—an average of 40,000 square feet per floor—making it the institution’s largest expansion since the Belfer Research Building opened in 2014. Laboratories in the new medical research center, which will open in 2026, will focus on a breadth of foundational, clinical and translational research, utilizing advanced data science and computational techniques to revolutionize scientists’ understanding of disease.
“This state-of-the-art new medical research center, only steps from where our doctors see patients, will enable investigators to share ideas and technologies; drive discovery across disciplines; attract and retain the brightest scientific minds; sustain growth in our research funding; and further a sense of community,” said Dr. Robert A. Harrington, the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine and provost for medical affairs of Cornell University. “By continuing to invest in science, we can change medicine, moving pioneering research more rapidly from lab concept to patient therapies.”
Weill Cornell Medicine’s research mission is a major focal point of the institution’s ambitious $1.5 billion We’re Changing Medicine fundraising campaign. This new facility will be essential for advancing research in key areas including neuroscience, immunotherapy, regenerative medicine, population health, women’s health and cardiovascular medicine, and will house the expansion of programs including the Englander Institute for Precision Medicine and the Meyer Cancer Center. By mining and analyzing large-scale data sets, a new Department of Systems and Computational Biomedicine will develop innovative algorithms and utilize machine learning and artificial intelligence to elevate all of Weill Cornell Medicine’s research efforts to better understand the basis of disease and identify new treatment strategies.
“Cornell’s enduring mission is to make a difference in our world through bold and visionary work,” said Martha E. Pollack, president of Cornell University. “Weill Cornell Medicine’s research expansion establishes the next frontier in scientific discovery and epitomizes our commitment to enhancing human health.”
